title: Emphasizing the value of phenotyping in patients receiving tamoxifen.
authors.forename: Frans L
authors.initials: FL
authors.lastname: Opdam
authors.forename: Vincent O
authors.initials: VO
authors.lastname: Dezentje
authors.forename: Jan
authors.initials: J
authors.lastname: den Hartigh
authors.forename: Henk-Jan
authors.initials: HJ
authors.lastname: Guchelaar
authors.forename: Hans
authors.initials: H
authors.lastname: Gelderblom
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000493:pharmacokinetics*; D001943:Breast Neoplasms / Q000188:drug therapy*; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D003915:Dextromethorphan; D005260:Female; D006801:Humans; D013629:Tamoxifen / Q000031:analogs & derivatives* / Q000493:pharmacokinetics*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen; D003915:Dextromethorphan; D019389:Cytochrome P-450 CYP2D6